Nature.comI like to fold it, fold itNature.comThis collection of thousands of new stable miniproteins with diverse topologies may themselves have applications in synthetic biology, and the insights gleaned from the way their global and sequence determi… Continue reading
Futurism |
CRISPR Co-Discoverer: “I’ve Never Seen Science Move at the Pace It’s Moving Now”
Futurism The CRISPR gene editing tool has already been used to perform some incredible feats of science, from manipulating the social behavior of ants to making superbugs kill themselves. It’s an incredibly powerful asset, but this week at CrisprCon, there was … Monsanto, ToolGen enter Crispr licensing pactWorld Grain |
Drug Discovery & Development |
Scientists Develop Novel Immunotherapy Technology for Prostate Cancer
Drug Discovery & Development A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein. This is the first … |
|
Blastic Plasmacytoid Dendritic Neoplasm Study Begins for CAR T-Cell Candidate
Rare Disease Report Cellectis announced today that the Phase 1 clinical study testing their CAR T-cell therapy, UCART123, to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) at the MD Anderson Cancer Center has begun, and the first patient was given the drug. Cellectis Starts BPDCN Phase I Trial with Gene-Edited CAR–T TherapyGenetic Engineering & Biotechnology News (blog) |